Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Marat Fudim Added: 1 year ago
In this short interview, Dr Marat Fudim offers a preview of his upcoming manuscript, set to appear in the Sleep Disordered Breathing in Heart Failure special focus collection in Cardiac Failure Review. He discusses the evolving role of home sleep testing in diagnosing sleep apnea in patients with heart failure, addressing key considerations in clinical workflows and patient selection.Watch now to… View more
Author(s): Heba Wassif Added: 6 months ago
Navigate the diagnostic and therapeutic landscape of autoimmune disorders and cardiomyopathy with Dr Heba WassifThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical intersection between immune-mediated inflammatory disorders and cardiovascular disease.Dr Wassif examines the spectrum and epidemiology of immune-mediated inflammatory disorders, emphasizing their… View more
Author(s): Milton Packer Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more
Author(s): Barry Borlaug Added: 8 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT… View more
Added: 8 months ago Source:  Radcliffe Cardiology
Sleep-disordered breathing (SDB), a condition mediated by intermittent hypoxaemia and autonomic dysregulation, is a well-established contributor to cardiovascular morbidity. A new prospective cohort study suggests that patients with hypertrophic cardiomyopathy (HCM) are particularly at risk, revealing a high prevalence of previously undiagnosed SDB in this population. The research links the… View more